Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Kersey
K. Kersey
Trastuzumab
Medicine
Pathology
Cancer research
Hsp90 inhibitor
3
Papers
71
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I trial of alvespimycin (KOS-1022; 17-DMAG) and trastuzumab (T)
2016
Journal of Clinical Oncology
Kathy D. Miller
Lee S. Rosen
Shanu Modi
Bryan P. Schneider
J. Roy
Linnea Chap
M. Paulsen
K. Kersey
Alison L. Hannah
Clifford A. Hudis
Show All
Source
Cite
Save
Citations (16)
Pawnee Nation Energy Option Analyses
2009
M. Matlock
K. Kersey
C. Riding In
Show All
Source
Cite
Save
Citations (0)
Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)
2008
Journal of Clinical Oncology
Shanu Modi
Steven Sugarman
Alison T. Stopeck
Hannah M. Linden
W. Ma
K. Kersey
Robert Johnson
Neal Rosen
Alison L. Hannah
C. Hudis
Show All
Source
Cite
Save
Citations (55)
1